Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia

Isra''l-Biet D; Esvant H; Laval A M; Cadranel J
March 2004
Thorax;Mar2004, Vol. 59 Issue 3, p247
Academic Journal
BACKGROUND: Pneumocystis jerovici pneumonia (PJP) remains a frequent opportunistic infection in HIV infected patients which markedly upregulates HIV replication by mechanisms so far poorly elucidated. PJP triggers the production of proinflammatory mediators with activating effects on HIV. However, anti-inflammatory factors with inhibiting effects on HIV are normally produced in parallel. We postulated that an imbalance of mediators normally controlling HIV replication could underlie its marked increase during PJP. METHODS: The production of tumour necrosis factor alpha (TNFalpha), interleukins IL-6 and IL-10, and beta-chemokine by bronchoalveolar lavage (BAL) cells recovered from HIV infected patients with and without PJP was compared. The pulmonary viral load was determined and correlations with cytokine and chemokine production were examined. RESULTS: TNFalpha and IL-6 release was similar in patients with and without PJP but IL-10 and beta-chemokine release was markedly lower in the PJP group (IL-10: p<10(-2), RANTES, MIP-1alpha and MIP-1beta: p<0.001). The pulmonary viral load was markedly higher in patients with PJP (p<0.001) and correlated negatively with levels of MIP-1alpha, RANTES and IL-10 in BAL fluid cells (p<0.05). CONCLUSION: Pulmonary IL-10 and beta-chemokine production is markedly defective in HIV infected patients with PJP, while pulmonary TNFalpha and IL-6 levels are normal. The resulting excess of these latter factors, which are known to upregulate HIV replication, might contribute to the increase in pulmonary viral load and to the more rapid HIV disease progression observed in patients with PJP.


Related Articles

  • Nonspecific Interstitial Pneumonitis without Evidence of Pneumocystis carinii in Asymptomatic Patients Infected with Human Immunodeficiency Virus (HIV). Ognibene, Frederick P.; Masur, Henry; Rogers, Paul; Travis, William D.; Suffredini, Anthony F.; Feuerstein, Irwin; Gill, Vee J.; Baird, Barbara F.; Carrasquillo, Jorge A.; Parrillo, Joseph E.; Lane, H. Clifford; Shelhamer, James H. // Annals of Internal Medicine;12/1/88, Vol. 109 Issue 11, p874 

    Presents a study which assessed how often Pneumocystis carinii organisms, P. carinii pneumonia, or other pulmonary pathologic processes were present in persons infected with HIV without pulmonary symptoms or previous history of P. carinii and with a normal chest roentgenogram. Theories that...

  • HIV+ patients still need PCP prophylaxis.  // AIDS Alert;Jul2007, Vol. 22 Issue 7, p80 

    The article reports that prophylaxis against pneumocystic carinii pneumonia (PCP) remains the single most cost-effective intervention in HIV+ patients at risk.

  • Breathless uncertainty.  // BMJ: British Medical Journal (International Edition);1/21/95, Vol. 310 Issue 6973, p199 

    Reports on how pneumocytis carinii pneumonia affects HIV positive patients. Effects of the disease; Treatment with intravenous cotrimoxazole; Side effect of medication; Living with HIV.

  • Letters to the Editor. May, Todd A.; Gruta, Cristina I.; Goldschmidt, Ronald H. // American Family Physician;10/15/2000, Vol. 62 Issue 8, p1783 

    Reports on the prevalence of pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus. Decline of AIDS cases with PCP with the advent of potent antiretroviral therapy.

  • Impact of Bacterial Pneumonia and Pneumocystis carinii Pneumonia on Human Immunodeficiency Virus Disease Progression. Osmond, Dennis H.; Chin, Daniel P.; Glassroth, Jeffrey; Kvale, Paul A.; Wallace, Jeane M.; Rosen, Mark J.; Reichman, Lee B.; Poole, W. Kenneth; Hopewell, Philip C. // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p536 

    Studies the effects of two species of pneumonia-causing bacteria on the progression of HIV among infected individuals. Comparison of median survival rates and CD4 lymphocyte counts among HIV infected and non-infected groups; Implications of the similarities of the effects of bacterial pneumonia...

  • Editorial Response: Do Bacterial Pneumonia and Pneumocystis carinii Pneumonia Accelerate Progression of Human Immunodeficiency Virus Disease? Kaplan, Jonathan E.; Janoff, Edward N.; Masur, Henry // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p544 

    Comments on the study by D.H. Osmond and colleagues on the effects of bacterial pneumonia on the progress of HIV in infected persons. Association of the occurrence of bacterial pneumonia and the accelerated progression of the HIV disease; Challenges of preventing bacterial pneumonia among...

  • Pulmonary Colonization with Pneumocystis carinii in Human Immunodeficiency Virus--Negative... Nevez, Gilles; Raccurt, Christian; Vincent, Pascal; Jounieaux, Vincent; Dei-Cas, Eduardo // Clinical Infectious Diseases;11/1/1999, Vol. 29 Issue 5, p1331 

    Reports on the pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus (HIV)-negative patients who had blood CD4 T cell counts. Laboratory tests conducted to detect P. carinii in bronchoalveolar lavage (BAL) fluid specimens of HIV-negative adult patients; Underlying...

  • PNEUMOCYSTIS CARINII PNEUMONIA CHEMOPROPHYLAXIS IN HIV+ PATIENTS IN GLASGOW: AN AUDIT. Wardle, D.M.; Kennedy, D. // Sexually Transmitted Infections;Jun2003 Supplement 1, Vol. 79, pA22 

    Introduction: We audited chemoprophylactic use against Pneumocystis carinii pneumonia (PCP) in our HIV+ patients using US Public Health Service and Infectious Diseases Society of America USPHS/IDSA guidelines as a standard in the absence of definitive UK guidelines. Methods: Criteria for...

  • Pneumocystis pneumonia in HIV-positive adults, Malawi. Van Oosterhout, Joep J. G.; Laufer, Miriam K.; Perez, M. Arantza; Graham, Stephen M.; Chimbiya, Nelson; Thesing, Phillip C.; Álvarez-Martinez, Miriam J.; Wilson, Paul E.; Chagomerana, Maganizo; Zijlstra, Eduard E.; Taylor, Terrie E.; Plowe, Christopher V.; Meshnick, Steven R.; Alvarez-Martinez, Miriam J // Emerging Infectious Diseases;Feb2007, Vol. 13 Issue 2, p325 

    In a prospective study of 660 HIV-positive Malawian adults, we diagnosed Pneumocystis jirovecii pneumonia (PcP) using clinical features, induced sputum for immunofluorescent staining, real-time PCR, and posttreatment follow-up. PcP incidence was highest in patients with the lowest CD4 counts,...


Read the Article


Sign out of this library

Other Topics